Expertise in
4
conditions

Michael M. Vickers

501 Smyth Road, 
Ottawa, ON, CA 
Expertise in
4
conditions
501 Smyth Road, 
Ottawa, ON, CA 

Overview

Michael Vickers practices practicing medicine in Ottawa, Canada.

Mr. Vickers is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Magnesium Deficiency, Pancreatic Cancer, and Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).

He is actively involved in clinical research, co-authoring 58 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

501 Smyth Road, Ottawa, ON K1H8L6, Canada
Other Locations
Calgary, AB, Canada
Calgary, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized Phase III Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
A Randomized Phase III Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind Study of Pamrevlumab or Placebo in Combination With Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX as Neoadjuvant Treatment in Patients With Locally Advanced, Unresectable Pancreatic Cancer
A Phase 3, Randomized, Double-Blind Study of Pamrevlumab or Placebo in Combination With Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX as Neoadjuvant Treatment in Patients With Locally Advanced, Unresectable Pancreatic Cancer
Enrollment Status: Completed
Publish Date: November 05, 2024
Intervention Type: Drug
Study Drugs: Pamrevlumab, Gemcitabine, Nab-paclitaxel, FOLFIRINOX
Study Phase: Phase 3
View 1 Less Clinical Trial

58 Total Publications

Corrigendum to "A non-randomized phase 2 trial of pembrolizumab in untreated patients with carcinoma of unknown primary site" [Eur J Cancer (2026) 239 116709].
Corrigendum to "A non-randomized phase 2 trial of pembrolizumab in untreated patients with carcinoma of unknown primary site" [Eur J Cancer (2026) 239 116709].
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 17, 2026

Frequently Asked Questions about Michael M. Vickers

Is Michael M. Vickers a top-rated expert for Colorectal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Michael M. Vickers is classified as an Advanced expert for Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Michael M. Vickers participate in research or clinical trials?

Yes. Michael M. Vickers has published 58 articles and abstracts on conditions like Colorectal Cancer. You can view a list of Michael M. Vickers's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Vickers's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile